search
  • Home
  • About Us
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • News
    • Events
    • Careers
  • Research & Pipeline
    • Paxalisib
    • Cantrixil
    • Collaborations
    • Publications & Presentations
  • Partnering
  • Investor Centre
    • ASX Announcements
    • SEC Filings
    • Company Reports
    • Company Meetings
    • Corporate Presentations
    • Analyst Reports
    • Investor Newsletters
    • Shareholder Services
    • COVID-19
    • Entitlement Offer
  • Media Centre
    • Video
    • Insights
MENU
  • Home
  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
    • Corporate Governance
    • News
    • Events
    • Careers
  • Research & Pipeline
    • Overview
    • Paxalisib
    • Cantrixil
    • Test
    • Collaborations
    • Publications & Presentations
  • Partnering
  • Investor Centre
    • Overview
    • ASX Announcements
    • SEC Filings
    • Company Reports
    • Company Meetings
    • Corporate Presentations
    • Analyst Reports
    • Investor Newsletters
    • Shareholder Services
    • COVID-19
    • Entitlement Offer
  • Media Centre
    • Video
    • Insights
  • CONTACT US
  • /
  • about us
  • /
  • Corporate Governance
  • About Us
  • Overview
  • Board Of Directors
  • Scientific Advisory Board
  • Corporate Governance
  • News
  • Events
  • Careers
  • Kazia Therapeutics follows the highest standards of corporate governance so as to drive sustainable, long-term shareholder value while recognising our broader obligations to a wide range of stakeholders.

  • November 2020

    Employee Share Option Plan

  • August 2020

    Corporate Governance Statement

  • August 2020

    Expanded Access Policy

  • February 2020

    Value Statement

  • January 2020

    Whistleblowing Policy

  • August 2019

    Board charter

  • August 2019

    Audit Risk and Governance Charter

  • August 2019

    Remuneration and Nominations Charter

  • August 2019

    Code of Business Conduct and Ethics

  • August 2019

    Securities Trading

  • August 2019

    Continuous Disclosure

  • August 2019

    Shareholder Communications

  • November 2017

    Constitution

  • SITE MAP
  • /
  • PRINT PAGE
  • /
  • TERMS OF USE
  • /
  • PRIVACY

  • FORWARD-LOOKING STATEMENTS
  • /
  • COOKIE POLICY
SITE BY SPATIAL DESIGN